Monas OFT 5 mg (Flash Tablet)

Unit Price: ৳ 9.00 (3 x 10: ৳ 270.00)
Strip Price: ৳ 90.00

Medicine Details

Category Details
Generic Montelukast sodium
Company Acme laboratories ltd
Also available as
Monas 4 mg chewable tablet Monas 5 mg chewable tablet Monas 10 mg tablet Monas oft 4 mg flash tablet

Title

  • Monas OFT 5 mg Flash Tablet

Categories

  • Medicine
  • Pharmaceutical

Indications

  • Prophylaxis and chronic treatment of asthma
  • Acute prevention of Exercise-Induced Bronchoconstriction (EIB)
  • Relief of symptoms of Allergic Rhinitis (AR): Seasonal & Perennial Allergic Rhinitis

Pharmacology

  • Montelukast is a selective and orally active leukotriene receptor antagonist that inhibits the cysteinyl leukotriene receptor (CysLT1)

Dosage & Administration

  • Adults and adolescents dosage: Montelukast 10 mg tablet once daily
  • Pediatric patients dosage: Montelukast 5 mg/4 mg tablet once daily
  • No dosage adjustment required in patients with mild-to-moderate hepatic/renal insufficiency

Interaction

  • No clinically important effects on the pharmacokinetics of certain drugs observed
  • Used concomitantly with a wide range of commonly prescribed drugs in clinical studies without evidence of clinical adverse interactions

Contraindications

  • Contraindicated in patients who are hypersensitive to any component of this product

Side Effects

  • Common side effects: Diarrhoea, fever, headache, nausea
  • Uncommon side effects: Anxiety, dizziness, dry mouth
  • Rare side effects: Angioedema, concentration impaired, hallucination

Pregnancy & Lactation

  • Montelukast crosses the placenta in rats and rabbits, caution during pregnancy and lactation

Precautions & Warnings

  • Not indicated for use in the reversal of bronchospasm in acute asthma attacks
  • Should not be abruptly substituted for inhaled or oral corticosteroids
  • Not to be used as monotherapy for the treatment of exercise-induced bronchospasm

Overdose Effects

  • Most frequently occurring adverse experiences: abdominal pain, somnolence, vomiting

Therapeutic Class

  • Leukotriene receptor antagonists

Storage Conditions

  • Store in cool & dry place below 30°C, protect from light & moisture

Chemical Structure

  • Molecular Formula: C35H36ClNO3S

Common Questions

  • What is Monas OFT 5 mg Flash Tablet?
  • What is Monas OFT 5 mg Flash Tablet used for?
  • How soon can the effect of Monas OFT 5 mg Flash Tablet be observed?
  • How long does the effect of Monas OFT 5 mg Flash Tablet last?
  • Should I use Monas OFT 5 mg Flash Tablet empty stomach?
  • What if I miss a dose of Monas OFT 5 mg Flash Tablet?
  • Are there any pregnancy warnings for Monas OFT 5 mg Flash Tablet?
  • General usage instructions

Usability

  • Daily dose for adults and adolescents
  • Availability in pediatric dosage forms
  • No need for dosage adjustments in patients with hepatic/renal insufficiency
  • Usable during acute exacerbations of asthma
  • Not a fast-acting rescue medicine for asthma attacks

Molecular Information

  • Chemical Structure: C35H36ClNO3S
  • Molecular formula
  • Plasma half-life in the elderly

Clinical Studies

  • Safety and efficacy established in pediatric patients
  • Profiles in pediatric patients similar to those seen in adults
  • Studies validating use in patients with aspirin sensitivity

Drug Safety

  • No apparent increase in adverse reactions when used with routine asthma therapies
  • No clinically important effects on the pharmacokinetics of certain drugs observed
  • Used concomitantly with a wide range of commonly prescribed drugs in clinical studies without evidence of adverse interactions

Functionality

  • Prophylaxis and chronic treatment of asthma
  • Acute prevention of Exercise-Induced Bronchoconstriction (EIB)
  • Relief of symptoms of allergic rhinitis
  • Improving airway function in asthmatics with documented aspirin sensitivity

Safety Information

  • Caution during pregnancy and lactation
  • Patients with known aspirin sensitivity should continue avoiding aspirin or non-steroidal anti-inflammatory agents when taking the product
  • No adverse experiences in the majority of overdosage reports

Common Concerns

  • Pregnancy warnings
  • Missed dose instructions
  • General instructions for usage

Characteristics

  • Orally active leukotriene receptor antagonist
  • Selective inhibition of the cysteinyl leukotriene receptor
  • Similar pharmacokinetic profile and oral bioavailability in elderly and younger adults

Effects Duration

  • Lasts for an average duration of 24 hours

Administration Guidance

  • Take exactly as prescribed by the doctor
  • Avoid abrupt substitution for inhaled or oral corticosteroids
  • Not to be used as monotherapy for the treatment of exercise-induced bronchospasm

Pediatric Usage

  • Dosage for pediatric patients in different age groups
  • Administering oral granules to younger pediatric patients

Hepatic/Renal Insufficiency

  • No dosage adjustment in patients with mild-to-moderate hepatic/renal insufficiency

Clinical Monitoring

  • Employ appropriate clinical monitoring when potent cytochrome P450 enzyme inducers are co-administered with the product

Adverse Effect Management

  • Remove unabsorbed material from the gastrointestinal tract in the event of overdose
  • Employ clinical monitoring and supportive therapy if required

Related Brands